Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: A pilot study

Respiratory Medicine

Volumn 104, Issue 3, 2010, Pages 412-417

  Pasqua, Franco ^a   Biscione, Gianluca ^a   Crigna, Girolmina ^a   Auciello, Laura ^a   Cazzola, Mario ^b  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b Unit of Respiratory Clinical Pharmacology   (Italy)

Author keywords

COPD; Pulmonary rehabilitation; Tiotropium; Triple therapy

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; OXYGEN; PLACEBO; TIOTROPIUM BROMIDE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXEMIA; KINESIOTHERAPY; LUNG FUNCTION; MALE; OXYGEN THERAPY; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WALKING;

AGED; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

EID: 76449083481     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.10.005     Document Type: Article

References (28)

1. Pepin V., Laviolette L., Saey D., and Maltais F. Synergetic interactions between rehabilitation and pharmacotherapy in COPD. Clin Invest Med 29 (2006) 170-177
2. Plankeel J.F., McMullen B., and MacIntyre N.R. Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest 127 (2005) 110-116
3. American Thoracic Society. Pulmonary rehabilitation. Am J Respir Crit Care Med 159 (1999) 1666-1682
4. Lacasse Y., Goldstein R., Lasserson T.J., and Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4 (2006) CD003793
5. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
6. Casaburi R., Kukafka D., Cooper C.B., Witek Jr. T.J., and Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127 (2005) 809-817
7. Troosters T., Casaburi R., Gosselink R., and Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 19-38
8. Watz H., Waschki B., Meyer T., and Magnussen H. Physical activity in patients with COPD. Eur Respir J 33 (2009) 262-272
9. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., et al. Standardisation of the measurement of lung volumes. Eur Respir J 26 (2005) 511-522
10. Miller M.R., Crapo R., Hankinson J., Brusasco V., Burgos F., Casaburi R., et al. General considerations for lung function testing. Eur Respir J 26 (2005) 153-161
11. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
12. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982) 377-381
13. Cazzola M., Di Marco F., Santus P., Boveri B., Verga M., Matera M.G., et al. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther 17 (2004) 35-39
14. Freiman J.A., Chalmers T.C., Smith H., and Kuebler R. The importance of β, the type II error, and sample size in the design and interpretation of the randomized controlled trial. In: Bailar J.C., and Mosteller F. (Eds). Medical uses of statistics (1992), NEJM Books, Boston, Ma 357-373
15. Geddes E.L., Reid W.D., Crowe J., O'Brien K., and Brooks D. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review. Respir Med 99 (2005) 1440-1458
16. Ambrosino N., Foglio K., Balzano G., Paggiaro P.L., Lessi P., and Kesten S. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance. Int J Chron Obstruct Pulmon Dis 3 (2008) 771-780
17. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007) 775-789
18. Troosters T., Gosselink R., and Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 109 (2000) 207-212
19. Lacasse Y., Martin S., Lasserson T.J., and Goldstein R.S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 43 (2007) 475-485
20. Pepin V., Brodeur J., Lacasse Y., Milot J., Leblanc P., Whittom F., et al. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 62 (2007) 291-298
21. Morgan M.D., and Singh S.J. Assessing the exercise response to a bronchodilator in COPD: time to get off your bike?. Thorax 62 (2007) 281-283
22. Cazzola M., Biscione G.L., Pasqua F., Crigna G., Appodia M., Cardaci V., et al. Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD. Respir Med 102 (2008) 1425-1430
23. Vagaggini B., Costa F., Antonelli S., De Simone C., De Cusatis G., Martino F., et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med 103 (2009) 1224-1230
24. McKay S.E., Howie C.A., Thomson A.H., Whiting B., and Addis G.J. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. Thorax 48 (1993) 227-232
25. Jaeschke R., Guyatt G.H., Willan A., Cook D., Harper S., Morris J., et al. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax 49 (1994) 479-484
26. Cazzola M., Andò F., Santus P., Ruggeri P., Di Marco F., Sanduzzi A., et al. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD. Pulm Pharmacol Ther 20 (2007) 556-561
27. Singh D., Brooks J., Hagan G., Cahn A., and O'Connor B.J. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax 63 (2008) 592-598
28. Cazzola M., MacNee W., Martinez F.J., Rabe K.F., Franciosi L.G., Barnes P.J., et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31 (2008) 416-469